Computers can crunch drug simulations and drive innovation faster than
we've ever seen in our history.
The National Biomedical Computation Resource is developing tools that will
drive drug discovery to new heights. This can result in faster generation of
new molecular entities, and identify more candidates for drug development,
which means fatter product pipelines, and possibly better outcomes.